1. Home
  2. Browse
  3. HRA003890
HRA003890
   HRA003890.xlsx
Title:
Study on diagnosis, treatment and pathogenesis of ROSAH disease
Release date:
2025-02-02
Description:
We developed a highly effective inhibitor of ALPK1, and planned to conduct a preliminary in vitro efficacy study with peripheral blood mononuclear cells of patients to observe the inhibitory effect of ALPK1 inhibitor on inflammation, and further study the pathogenesis of ROASH through transcriptome and proteome analysis. The peripheral blood cells were differentiated into IPSC cells to study the mechanism and pharmacodynamics.
Data Accessibility:   
Controlled access Request Data
BioProject:
PRJCA014589
Study type:
Disease Study
Disease name:
monogenic disease
Data Access Committee

For each controlled access study, there is a corresponding Data Access Committee(DAC) to determine the access permissions. Access to actual data files is not managed by NGDC.


DAC NO.:
HDAC002183
DAC name:
ROSAH Disease Data Management
Contact person:
Song Hongmei
Email:
Songhm1021@126.com
Description:
Responsible for reviewing and authorizing requests for access to controlled data in accordance with consent forms and/or State research Ethics provisions.
Individuals & samples
Files
Request Data
Submitter:   Song Hongmei / Songhm1021@126.com
Organization:   Peking Union Hospital, Chinese Academy of Medical Sciences
Submission date:   2023-02-02
Requests:   -